Clinical Trials Directory

Trials / Unknown

UnknownNCT01520974

Effect of an Oral Probiotic Tablet on Oral Bacteria and Clinical Measurements (ProBiora3)

ProBiora3 Oral Care Probiotics Usage

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Oragenics, Inc. · Industry
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if an oral probiotic tablet taken once a day for twelve weeks can decrease the numbers of bacteria that are associated with tooth decay and gum disease in a dentally healthy, young adult population.

Detailed description

There are over 500 types of bacteria in the mouth. Most of these bacteria do not cause disease. However, some mouth bacteria can cause tooth decay and gum disease. The purpose of a probiotic tablet for the mouth is to put known healthy bacteria in the mouth. This study will compare the effect of the probiotic tablet on the levels of harmful or disease causing bacteria in the mouth to a placebo tablet that does not contain any probiotic bacteria.

Conditions

Interventions

TypeNameDescription
OTHERProBiora3 mintsProbiotic mint tablet taken once daily for 12 weeks containing ProBiora3, a combination of three known healthy bacteria
OTHERPlacebo tabletMint tablet taken once daily for 12 weeks without the ProBiora3 combination of three known healthy bacteria

Timeline

Start date
2012-01-01
Primary completion
2012-08-01
First posted
2012-01-30
Last updated
2012-05-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01520974. Inclusion in this directory is not an endorsement.